Updates on COVID-19: Virology, Etiology, Epidemiology, Pathogenesis, Diagnosis, Transmission and Prevention

Sumayea Kabir Saba, F. Khan, Samantha Lamia, Md. Iqbal Shahid, Tahsin Anika, S. Akhter, Khadizatul Fariha Chowdhury, Umma Mysha Tannum Arpita, Shanta Islam, Khandaker Amirul Momenin, Shah Alam, Kanij Fatima Tisha, Md. Jamal Hossain, Md. Harun Or Rashid, M. Sarker
{"title":"Updates on COVID-19: Virology, Etiology, Epidemiology, Pathogenesis, Diagnosis, Transmission and Prevention","authors":"Sumayea Kabir Saba, F. Khan, Samantha Lamia, Md. Iqbal Shahid, Tahsin Anika, S. Akhter, Khadizatul Fariha Chowdhury, Umma Mysha Tannum Arpita, Shanta Islam, Khandaker Amirul Momenin, Shah Alam, Kanij Fatima Tisha, Md. Jamal Hossain, Md. Harun Or Rashid, M. Sarker","doi":"10.3329/bpj.v25i2.60966","DOIUrl":null,"url":null,"abstract":"COVID-19 is a pandemic malady caused by SARS-CoV-2, a novel coronavirus. It is a global threat that has affected 223 countries and territories all over the world. According to the WHO report as of April 06, 2022 coronavirus has affected 492,189,439 people globally with 6,159,474 confirmed deaths. The pandemic of COVID-19 has badly affected Bangladesh likewise many other countries of the world. According to Worldometer report on 06 April 2022 the number of confirmed cases of COVID-19 were 1,951,903 with 29,123 deaths, and 1,886,036 COVID-19 recoveries in Bangladesh. After originating from China, this notorious virus has been spread to almost all the countries of the world. Its spike protein aids in binding with the ACE2 receptors of the cell membrane resulting in cell entry, replication, and induction of inflammatory and pro-inflammatory responses leading to the pathogenic condition. The novel COVID-19 virus has structural and genetic similarity with its predecessors specially SARS-CoV and MERS-CoV. This review presents the existing literature on COVID-19 and discusses different aspects of COVID-19 including virology, etiology, epidemiology, pathogenesis, diagnosis, transmission and susceptibility and preventive measures of COVID-19.\nBangladesh Pharmaceutical Journal 25(2): 143-163, 2022 (July)","PeriodicalId":8695,"journal":{"name":"Bangladesh Pharmaceutical Journal","volume":"30 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bangladesh Pharmaceutical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3329/bpj.v25i2.60966","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

COVID-19 is a pandemic malady caused by SARS-CoV-2, a novel coronavirus. It is a global threat that has affected 223 countries and territories all over the world. According to the WHO report as of April 06, 2022 coronavirus has affected 492,189,439 people globally with 6,159,474 confirmed deaths. The pandemic of COVID-19 has badly affected Bangladesh likewise many other countries of the world. According to Worldometer report on 06 April 2022 the number of confirmed cases of COVID-19 were 1,951,903 with 29,123 deaths, and 1,886,036 COVID-19 recoveries in Bangladesh. After originating from China, this notorious virus has been spread to almost all the countries of the world. Its spike protein aids in binding with the ACE2 receptors of the cell membrane resulting in cell entry, replication, and induction of inflammatory and pro-inflammatory responses leading to the pathogenic condition. The novel COVID-19 virus has structural and genetic similarity with its predecessors specially SARS-CoV and MERS-CoV. This review presents the existing literature on COVID-19 and discusses different aspects of COVID-19 including virology, etiology, epidemiology, pathogenesis, diagnosis, transmission and susceptibility and preventive measures of COVID-19. Bangladesh Pharmaceutical Journal 25(2): 143-163, 2022 (July)
COVID-19最新进展:病毒学、病因学、流行病学、发病机制、诊断、传播和预防
COVID-19是一种由新型冠状病毒SARS-CoV-2引起的大流行疾病。这是一种全球性威胁,已影响到全世界223个国家和地区。根据世界卫生组织的报告,截至4月6日,2022年冠状病毒已在全球范围内感染492,189,439人,确诊死亡6159,474人。2019冠状病毒病大流行给孟加拉国和世界许多其他国家造成了严重影响。根据2022年4月6日世界计量表的报告,孟加拉国新冠肺炎确诊病例为1,951,903例,死亡29,123例,康复1,886,036例。这种臭名昭著的病毒发源于中国,现在已经传播到世界上几乎所有的国家。其刺突蛋白有助于与细胞膜上的ACE2受体结合,导致细胞进入、复制,并诱导炎症和促炎症反应,从而导致致病性疾病。新型冠状病毒在结构和基因上与之前的病毒,特别是SARS-CoV和MERS-CoV具有相似性。本文综述了新冠肺炎相关文献,从病毒学、病原学、流行病学、发病机制、诊断、传播、易感及预防措施等方面对新冠肺炎进行了探讨。孟加拉国医药杂志25(2):143-163,2022(7月)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信